PRQR - ProQR Therapeutics N.V
IEX Last Trade
2.04
0.050 2.451%
Share volume: 163,816
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.99
0.05
2.51%
Summary score
24%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
21%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.83%
Return on assets
-16.82%
Return on sales
0%
Return on invested capital
222.21%
Total debt ratio
22.23%
Debt ratio change over timeo
-0.89%
Current Ratio
8.74%
Quick Ratio
0%
Cash Position Ratio
8.34%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.2%
Return on assets
-15.35%
Return on sales
0%
Return on invested capital
170.7%
Total debt ratio
20.31%
Debt ratio change over timeo
-0.9%
Current Ratio
9.64%
Quick Ratio
0%
Cash Position Ratio
10.18%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-5.03%
Return on assets
-12.62%
Return on sales
0%
Return on invested capital
60.29%
Total debt ratio
14.34%
Debt ratio change over time
-0.94%
Current Ratio
10.09%
Quick Ratio
0%
Cash Position Ratio
9.65%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.78%
Return on assets
-108.09%
Return on sales
0%
Return on invested capital
4.81%
Total debt ratio
-89.14%
Debt ratio change over time
-0.89%
Current Ratio
3.89%
Quick Ratio
0%
Cash Position Ratio
3.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRQR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.83% | -3.05% | 11.55% | 6.27% |
| Return on assets | -16.82% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 222.21% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 22.23% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.89% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 9.64% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.18% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 17% | 37% | 37% |
| Short-term ratios | PRQR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.2% | -25.62% | 17.94% | 7.14% |
| Return on assets | -15.35% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 170.7% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 71% | 60% |
| Total debt ratio | 20.31% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.9% | -23.44% | 9.66% | 0.6% |
| Dept financing | 5% | 25% | 45% | 8% |
| Current Ratio | 9.64% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.18% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 26% | 22% | 38% |